Medical Arts Health Research Group CEO, Donna Benson is pleased to announce that their Penticton Research Team along with the UBC Brain Institute have been selected as the only 2 sites in BC which have been awarded a study for a new drug treatment for Alzheimer’s.

To better understand why Alzheimer’s occurs and develop potential treatments, scientists and researchers found that brain tissue for someone with Alzheimer’s has far fewer nerve cells and synapses (junction between two nerve cells) than a healthy brain and plaques appear to build up between nerve cells. Plaques are formed when protein pieces called beta-amyloids get sticky and clump together.

The drug, an antibody, is thought to bind to the sticky clumps of the protein beta-amyloid in the brain and cause cells to digest away the plaque. Clinical studies this past spring showed patients experienced a significant reduction of beta-amyloid in the brain and importantly, a slowing of their clinical decline.

To find out if you or a loved one is eligible to participate in the study or for further information, please call The Medical Arts Health Research Group at 1.888.490.4320